Globus Medical, Inc. share price today

(GMED)

Globus Medical, Inc. share price is $83.09 & ₹7,032.99 as on 6 Dec 2024, 2.30 'hrs' IST

$83.09

▲

-1.32

(-1.56%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Globus Medical, Inc. share price in Dollar and Rupees. Guide to invest in Globus Medical, Inc. from India. Also see the sentimental analysis on Indian investors investing in Globus Medical, Inc.. Get details on the Indian mutual funds that are investing in Globus Medical, Inc.. Get Analyst recommendations and forecasts along with all the Globus Medical, Inc.'s financials.

Globus Medical, Inc. share price movements

$83.06
$84.13
$83.09
0.04%
Downside
Day's Volatility :1.27%
Upside
1.24%
$44.02
$87.22
$83.09
47.02%
Downside
52 Weeks Volatility :49.53%
Upside
4.74%

Globus Medical, Inc. Returns

Period	Globus Medical, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	18.72%	-5.7%	0.0%
6 Months	27.6%	-0.8%	0.0%
1 Year	83.3%	9.9%	0.0%
3 Years	20.56%	10.7%	-19.7%

Globus Medical, Inc. Key Statistics

in dollars & INR

Previous Close	$84.41
Open	$83.57
Today's High	$84.13
Today's Low	$83.06
Market Capitalization	$11.3B
Today's Volume	$581.7K
52 Week High	$87.22
52 Week Low	$44.02
Revenue TTM	$2.5B
EBITDA	$652.0M
Earnings Per Share (EPS)	$0.62
PE Ratio	134.02
Profit Margin	3.69%
Quarterly Earnings Growth YOY	42.23%
Return On Equity TTM	2.22%

How to invest in Globus Medical, Inc. from India?

It is very easy for Indian residents to invest directly in Globus Medical, Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Globus Medical, Inc. stock in both rupees (INR) and dollars (USD). Search for Globus Medical, Inc. or GMED on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Globus Medical, Inc. or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Globus Medical, Inc. shares which would translate to 0.010 fractional shares of Globus Medical, Inc. as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Globus Medical, Inc.

78%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Globus Medical, Inc. on INDmoney from India has grown in the last 30 days as on Dec 6, 2024. 78% more investors are searching Globus Medical, Inc. in the last 30 days versus the previous period.

Indian Mutual Funds that own Globus Medical, Inc.

Name	Shares Held	Change in Shares	% of Assets
DSP Healthcare Fund Direct Growth	268800	23912.45	5.30%

Global Institutional Holdings in Globus Medical, Inc.

Vanguard Group Inc
7.80%
BlackRock Inc
7.59%
HHG PLC
5.14%
State Street Corp
2.62%
JPMorgan Chase & Co
1.91%
Wellington Management Company LLP
1.89%

Analyst Recommendation on Globus Medical, Inc.

Buy

54%Buy

40%Hold

4%Sell

Based on 22 Wall street analysts offering stock ratings for Globus Medical, Inc.(by analysts ranked 0 to 5 stars)

Based on 22 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Globus Medical, Inc.

What analysts predicted

Upside of 10.54%

Current:

$83.09

Target:

$91.85

Insights on Globus Medical, Inc.

Decreasing Revenue
Revenue is down for the last 2 quarters, 629.69M → 625.70M (in $), with an average decrease of 0.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -7.11M → 51.83M (in $), with an average increase of 80.6% per quarter
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 122.4% return, outperforming this stock by 98.7%

Globus Medical, Inc. Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$713.0M	↑ 12.11%
Net Income	$156.5M	↑ 45.76%
Net Profit Margin	21.95%	↑ 5.07%

	FY19	Y/Y Change
Revenue	$785.4M	↑ 10.15%
Net Income	$155.2M	↓ 0.81%
Net Profit Margin	19.76%	↓ 2.19%

	FY20	Y/Y Change
Revenue	$789.0M	↑ 0.47%
Net Income	$102.3M	↓ 34.1%
Net Profit Margin	12.96%	↓ 6.8%

	FY21	Y/Y Change
Revenue	$958.1M	↑ 21.43%
Net Income	$149.2M	↑ 45.86%
Net Profit Margin	15.57%	↑ 2.61%

	FY22	Y/Y Change
Revenue	$1.0B	↑ 6.76%
Net Income	$190.2M	↑ 27.47%
Net Profit Margin	18.59%	↑ 3.02%

	FY23	Y/Y Change
Revenue	$1.6B	↑ 53.34%
Net Income	$122.9M	↓ 35.39%
Net Profit Margin	7.83%	↓ 10.76%

	Q2 FY23	Q/Q Change
Revenue	$291.6M	↑ 5.39%
Net Income	$57.7M	↑ 17.47%
Net Profit Margin	19.79%	↑ 2.03%

	Q3 FY23	Q/Q Change
Revenue	$383.6M	↑ 31.56%
Net Income	$998.0K	↓ 98.27%
Net Profit Margin	0.26%	↓ 19.53%

	Q4 FY23	Q/Q Change
Revenue	$616.5M	↑ 60.71%
Net Income	$15.0M	↑ 1406.41%
Net Profit Margin	2.44%	↑ 2.18%

	Q1 FY24	Q/Q Change
Revenue	$606.7M	↓ 1.6%
Net Income	$-7.1M	↓ 147.34%
Net Profit Margin	-1.17%	↓ 3.61%

	Q2 FY24	Q/Q Change
Revenue	$629.7M	↑ 3.8%
Net Income	$31.8M	↓ 546.26%
Net Profit Margin	5.04%	↑ 6.21%

	Q3 FY24	Q/Q Change
Revenue	$625.7M	↓ 0.63%
Net Income	$51.8M	↑ 63.21%
Net Profit Margin	8.28%	↑ 3.24%

	FY18	Y/Y Change
Total Assets	$1.3B	↑ 20.6%
Total Liabilities	$115.2M	↑ 4.0%

	FY19	Y/Y Change
Total Assets	$1.5B	↑ 17.79%
Total Liabilities	$129.6M	↑ 12.57%

	FY20	Y/Y Change
Total Assets	$1.7B	↑ 9.62%
Total Liabilities	$173.2M	↑ 33.61%

	FY21	Y/Y Change
Total Assets	$2.0B	↑ 16.54%
Total Liabilities	$215.9M	↑ 24.65%

	FY22	Y/Y Change
Total Assets	$2.1B	↑ 6.07%
Total Liabilities	$229.8M	↑ 6.43%

	FY23	Y/Y Change
Total Assets	$5.1B	↑ 144.98%
Total Liabilities	$1.1B	↑ 373.61%

	Q2 FY23	Q/Q Change
Total Assets	$2.2B	↑ 2.92%
Total Liabilities	$227.4M	↓ 3.15%

	Q3 FY23	Q/Q Change
Total Assets	$5.4B	↑ 142.08%
Total Liabilities	$1.2B	↑ 413.89%

	Q4 FY23	Q/Q Change
Total Assets	$5.1B	↓ 5.04%
Total Liabilities	$1.1B	↓ 6.89%

	Q1 FY24	Q/Q Change
Total Assets	$4.9B	↓ 2.8%
Total Liabilities	$1.0B	↓ 6.15%

	Q2 FY24	Q/Q Change
Total Assets	$5.0B	↑ 1.02%
Total Liabilities	$1.0B	↓ 0.37%

	Q3 FY24	Q/Q Change
Total Assets	$5.1B	↑ 1.85%
Total Liabilities	$1.0B	↓ 0.08%

	FY18	Y/Y Change
Operating Cash Flow	$181.6M	↑ 13.86%
Investing Cash Flow	$-193.0M	↑ 73.47%
Financing Cash Flow	$32.6M	↑ 1903.08%

	FY19	Y/Y Change
Operating Cash Flow	$172.0M	↓ 5.32%
Investing Cash Flow	$-140.3M	↓ 27.33%
Financing Cash Flow	$24.4M	↓ 24.96%

	FY20	Y/Y Change
Operating Cash Flow	$198.8M	↑ 15.59%
Investing Cash Flow	$-117.3M	↓ 16.37%
Financing Cash Flow	$-38.7M	↓ 258.2%

	FY21	Y/Y Change
Operating Cash Flow	$276.3M	↑ 38.98%
Investing Cash Flow	$-375.9M	↑ 220.43%
Financing Cash Flow	$54.1M	↓ 240.05%

	FY22	Y/Y Change
Operating Cash Flow	$178.5M	↓ 35.4%
Investing Cash Flow	$-110.4M	↓ 70.64%
Financing Cash Flow	$-110.0M	↓ 303.08%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$35.0M	↓ 34.3%
Investing Cash Flow	$52.2M	↑ 375.09%
Financing Cash Flow	$1.1M	↓ 63.13%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$50.5M	↑ 44.12%
Investing Cash Flow	$-80.9M	↓ 254.84%
Financing Cash Flow	$1.4M	↑ 31.46%

Globus Medical, Inc. Technicals Summary

Sell

Neutral

Buy

Globus Medical, Inc. is currently in a neutral trading position according to technical analysis indicators.

Globus Medical, Inc. Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Globus Medical, Inc.	0.46%	27.6%	83.3%	20.56%	44.91%
Stryker Corporation	3.64%	9.48%	32.16%	46.79%	90.84%
Boston Scientific Corp.	4.73%	17.4%	64.51%	118.67%	107.12%
Edwards Lifesciences Corp.	10.16%	-17.82%	6.11%	-37.3%	-7.26%
Abbott Laboratories	-1.04%	7.45%	11.09%	-12.71%	37.82%
Medtronic Plc	-6.63%	0.08%	5.77%	-25.06%	-24.29%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Globus Medical, Inc.	134.02	134.02	2.27	2.97	0.02	0.05	NA	29.94
Stryker Corporation	40.99	40.99	2.67	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	74.82	74.82	1.64	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.63	28.63	6.78	2.52	0.19	0.11	NA	16.18
Abbott Laboratories	35.24	35.24	2.25	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	26.38	26.38	1.56	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Globus Medical, Inc.	Buy	$11.3B	44.91%	134.02	3.69%
Stryker Corporation	Buy	$145.8B	90.84%	40.99	16.34%
Boston Scientific Corp.	Buy	$133.9B	107.12%	74.82	11.26%
Edwards Lifesciences Corp.	Buy	$42.7B	-7.26%	28.63	65.86%
Abbott Laboratories	Buy	$201.1B	37.82%	35.24	13.99%
Medtronic Plc	Buy	$110.6B	-24.29%	26.38	12.06%

About Globus Medical, Inc.

globus medical, inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. founded in 2003, globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. additional information can be accessed at www.globusmedical.com.

Organization	Globus Medical, Inc.
Employees	5000
CEO	Mr. David C. Paul
Industry	Health Technology

Management People of Globus Medical, Inc.

Name	Title
Mr. David C. Paul	Co-Founder & Executive Chairman
Mr. Daniel T. Scavilla	President, CEO & Director
Mr. Keith W. Pfeil	CFO & COO
Ms. Kelly G. Huller Esq.	Senior VP, General Counsel & Secretary
Mr. Brian J. Kearns	Senior Vice President of Business Development & Investor Relations

Important FAQs about investing in Globus Medical, Inc. from India :

What is Globus Medical, Inc. share price today?

Globus Medical, Inc. (GMED) share price today is $83.09.

Can Indians buy Globus Medical, Inc. shares?

Yes, Indians can invest in the Globus Medical, Inc. (GMED) from India.

With INDmoney, you can buy Globus Medical, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Globus Medical, Inc. at zero transaction cost.

How can I buy Globus Medical, Inc. shares from India?

It is very easy to buy Globus Medical, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Globus Medical, Inc. be purchased?

Yes, you can buy fractional shares of Globus Medical, Inc. with INDmoney app.

What are the documents required to start investing in Globus Medical, Inc. stocks?

To start investing in Globus Medical, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.